Crossmark

Long-term follow-up of half-fluence photodynamic therapy in acute central serous chorioretinopathy

Crossref DOI link: https://doi.org/10.1007/s00717-018-0412-y

Published Online: 2018-09-12

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Smretschnig, Eva

Hagen, Stefan

Gamper, Jutta

Krebs, Ilse

Binder, Susanne

Ansari-Shahrezaei, Siamak
License Information

Text and Data Mining valid from 2018-09-12
More Information

Article History

Received: 24 April 2018

Accepted: 28 August 2018

First Online: 12 September 2018

Compliance with ethical guidelines

:

: E. Smretschnig, S. Hagen, J. Gamper, I. Krebs, S. Binder, and S. Ansari-Shahrezaei declare that they have no competing interests.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.